| dc.contributor.author | García Domingo, Mónica | |
| dc.contributor.author | Morán Benito, Asunción | |
| dc.contributor.author | Martín Calvo, María Luisa | |
| dc.contributor.author | Barthelmebs, Mariette | |
| dc.contributor.author | San Román, Luis | |
| dc.date.accessioned | 2024-07-31T11:26:52Z | |
| dc.date.available | 2024-07-31T11:26:52Z | |
| dc.date.issued | 2006-05-10 | |
| dc.identifier.citation | García, M., Morán, A., Martín, M. L., Barthelmebs, M., & San Román, L. (2006). The nitric oxide synthesis/pathway mediates the inhibitory serotoninergic responses of the pressor effect elicited by sympathetic stimulation in diabetic pithed rats. European journal of pharmacology, 537(1-3), 126-134. | es_ES |
| dc.identifier.issn | 0014-2999 | |
| dc.identifier.uri | http://hdl.handle.net/10366/159278 | |
| dc.description.abstract | [EN]We investigated the involvement of the nitric oxide pathway in the inhibitory mechanisms of 5-hydroxytryptamine (5-HT) in the pressor responses induced by stimulation of sympathetic vasopressor outflow in diabetic pithed rats. Diabetes was induced in male Wistar rats by a single s.c. injection of alloxan. Four weeks later, the animals were anaesthetized, pretreated with atropine, and pithed. Electrical stimulation of the sympathetic outflow from the spinal cord (0.1, 0.5, 1 and 5 Hz) resulted in frequency-dependent increases in blood pressure. The inhibition of electrically induced pressor responses by 5-HT (10 microg/kg/min) in diabetic pithed rats could not be elicited after i.v. treatment with 1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) (10 microg/kg), a guanylyl cyclase inhibitor, or N-omega-L-Arginine methyl ester hydrochloride (L-NAME) (10 mg/kg), a nitric oxide synthase (NOS) inhibitor. The inhibitory effect produced by infusion of the selective 5-HT(1A) receptor agonist 8-hydroxydipropylaminotretalin hydrobromide (8-OH-DPAT) (20 microg/kg/min) was abolished in the presence of ODQ (10 microg/kg), or L-NAME (10 mg/kg) in diabetic pithed rats. The administration of L-Arginine (100 mg/kg) 30 min after L-NAME reproduced the inhibitory effect caused by 5-HT (10 microg/kg/min) and 8-OH-DPAT (20 microg/kg/min) on the electrically induced pressor responses, whereas in the presence of D-Arginine (100 mg/kg)+L-NAME the 5-HT or 8-OH-DPAT inhibitory effect on the pressor responses was abolished. In conclusion, in diabetic pithed rats, the inhibition produced by prejunctional 5-HT(1A) activation on electrically induced sympathetic pressor responses is mediated by the NO synthesis/pathway. | es_ES |
| dc.format.mimetype | application/pdf | |
| dc.language.iso | eng | es_ES |
| dc.subject | 5-hydroxytryptamine | es_ES |
| dc.subject | Nitric oxide | es_ES |
| dc.subject | Experimental diabetes | es_ES |
| dc.subject | 5-HT1A receptors | es_ES |
| dc.subject | Prejunctional inhibition | es_ES |
| dc.subject.mesh | NG-Nitroarginine Methyl Ester | * |
| dc.subject.mesh | Nitric Oxide Synthase | * |
| dc.subject.mesh | Diabetes Mellitus | * |
| dc.subject.mesh | Electric Stimulation | * |
| dc.subject.mesh | 8-Hydroxy-2-(di-n-propylamino)tetralin | * |
| dc.subject.mesh | Atropine | * |
| dc.subject.mesh | Norepinephrine | * |
| dc.subject.mesh | Nitric Oxide | * |
| dc.subject.mesh | Blood Pressure | * |
| dc.subject.mesh | Oxadiazoles | * |
| dc.subject.mesh | Serotonin | * |
| dc.subject.mesh | Enzyme Inhibitors | * |
| dc.subject.mesh | Quinoxalines | * |
| dc.subject.mesh | Spinal Cord | * |
| dc.subject.mesh | Muscarinic Antagonists | * |
| dc.subject.mesh | Guanylate Cyclase | * |
| dc.subject.mesh | Rats | * |
| dc.subject.mesh | Animals | * |
| dc.subject.mesh | Serotonin 5-HT1 Receptor Agonists | * |
| dc.subject.mesh | Vasoconstriction | * |
| dc.subject.mesh | Tryptamines | * |
| dc.subject.mesh | Serotonin Receptor Agonists | * |
| dc.title | The nitric oxide synthesis/pathway mediates the inhibitory serotoninergic responses of the pressor effect elicited by sympathetic stimulation in diabetic pithed rats. | es_ES |
| dc.type | info:eu-repo/semantics/article | es_ES |
| dc.relation.publishversion | https://doi.org/10.1016/j.ejphar.2006.03.020 | es_ES |
| dc.subject.unesco | 3209 Farmacología | es_ES |
| dc.identifier.doi | 10.1016/j.ejphar.2006.03.020 | |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | es_ES |
| dc.identifier.pmid | 16630608 | |
| dc.journal.title | European Journal of Pharmacology | es_ES |
| dc.volume.number | 537 | es_ES |
| dc.issue.number | 1-3 | es_ES |
| dc.page.initial | 126 | es_ES |
| dc.page.final | 134 | es_ES |
| dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | es_ES |
| dc.subject.decs | vasoconstricción | * |
| dc.subject.decs | inhibidores enzimáticos | * |
| dc.subject.decs | óxido nítrico | * |
| dc.subject.decs | estimulación eléctrica | * |
| dc.subject.decs | guanilato ciclasa | * |
| dc.subject.decs | agonistas de receptores de serotonina 5-HT1 | * |
| dc.subject.decs | NG-nitroarginina metil éster | * |
| dc.subject.decs | serotonina | * |
| dc.subject.decs | norepinefrina | * |
| dc.subject.decs | atropina | * |
| dc.subject.decs | presión sanguínea | * |
| dc.subject.decs | óxido nítrico sintasa | * |
| dc.subject.decs | triptaminas | * |
| dc.subject.decs | animales | * |
| dc.subject.decs | 8-hidroxi-2-(di-n-propilamino)tetralina | * |
| dc.subject.decs | agonistas de receptores de serotonina | * |
| dc.subject.decs | médula espinal | * |
| dc.subject.decs | ratas | * |
| dc.subject.decs | diabetes mellitus | * |
| dc.subject.decs | oxadiazoles | * |
| dc.subject.decs | quinoxalinas | * |
| dc.subject.decs | antagonistas muscarínicos | * |
Stöbern
Gesamter BestandBereiche & SammlungenErscheinungsdatumAutorenSchlagwortenTitelnDiese SammlungErscheinungsdatumAutorenSchlagwortenTiteln
Mein Benutzerkonto
Statistiken
ENLACES Y ACCESOS
Derechos de autorPolíticasGuías de autoarchivoFAQAdhesión USAL a la Declaración de BerlínProtocolo de depósito, modificación y retirada de documentos y datosSolicitud de depósito, modificación y retirada de documentos y datos







